Ticker Symbol: PMCB

PharmaCyte Biotech Inc

$2.74 - 17-09-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001157075

Company Profile

PharmaCyte Biotech, Inc. is a biotechnology company developing cellular therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as "Cell-in-a-Box®." This technology is being used as a platform upon which therapies for several types of cancer and diabetes are being developed. PharmaCyte’s therapy for cancer involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active or "cancer-killing" form.

Sector: Manufacturing

Industry: Biological Product (except Diagnostic) Manufacturing

Standard Industrial Classification Code (SIC code): 2836

Address: N/A

Website: www.pharmacytebiotech.com

CEO: N/A

Tags:

Consumer Sundries
Consumer Non-Durables
Manufacturing
Medicinal and Botanical Manufacturing

Pricing

Last Updated: October 3, 2023 03:00 PM EST

Previous Close: $2.06

Change: -$0.18 ( -8.00%)

Days Range: $2.06 - $2.25

Beta: 0.34

52wk. High: $3.23

52wk. Low: $2.00

Ytd. Change -31.21%

50 Day Moving Average: $2.25

200 Day Moving Average: $2.70

Shares Outstanding: 8778101

Valuation

Market Cap: 1.8B

PE Ratio: -

EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A